Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

Original Article

H. Al-Samkari, C. Muñoz, Ç. Geredeli, I. Korantzis, B.G. Astorga, C. Arslan, J.F.C. Camargo, F. Scotté, G. Borges, K. Wang, M. Eisen, D.J. Kuter, and G.A. Soff

N Engl J Med 2026;394:1061-1073

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
03/11/2026
Course expires: 
03/12/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.